Mutation is in the DNA-binding domain (numbering with respect to the EcR-B1 open reading frame).
Nucleotide substitution: G?A.
Amino acid replacement: C300Y.
G6094852A
G?A
C271Y | EcR-PA; C300Y | EcR-PB; C91Y | EcR-PC; C271Y | EcR-PD; C271Y | EcR-PE; C300Y | EcR-PG
C300Y
EcRC300Y, Hsc70-4195/Hsc70-4[+] has visible | dominant phenotype
EcRC300Y/EcR[+], Hsc70-4195 has visible | dominant phenotype
EcRC300Y, Sin3A08269 has viable phenotype
EcRC300Y, Sin3A08269 has wild-type phenotype
EcRC300Y/EcR[+], Sin3A08269 has viable phenotype
EcRC300Y/EcR[+], Sin3A08269 has wild-type phenotype
EcRC300Y, Sin3A[+]/Sin3A08269 has viable phenotype
EcRC300Y, Sin3A[+]/Sin3A08269 has wild-type phenotype
EcRC300Y, Hsc70-4195/Hsc70-4[+] has wing phenotype
EcRC300Y, Hsc70-4195/Hsc70-4[+] has leg phenotype
EcRC300Y/EcR[+], Hsc70-4195 has wing phenotype
EcRC300Y/EcR[+], Hsc70-4195 has leg phenotype
In transheterozygous combination with Hsc70-4195, wings are frequently blistered and legs are occasionally malformed. This enhancement is completely suppressed by P{Hsc70-4.14}.
EcRC300Y/Sin3A08269 transheterozygotes show normal viability and no visible phenotype.